SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001144204-19-029506
Filing Date
2019-06-03
Accepted
2019-06-03 17:10:17
Documents
13
Effectiveness Date
2019-06-03

Document Format Files

Seq Description Document Type Size
1 DEFR14A tv522762_defr14a.htm DEFR14A 673182
2 GRAPHIC tv522762_img01.jpg GRAPHIC 5417
3 GRAPHIC tv522762_img02.jpg GRAPHIC 181134
4 GRAPHIC tv522762_img03.jpg GRAPHIC 300455
5 GRAPHIC tv522762_img04.jpg GRAPHIC 71138
6 GRAPHIC tv522762_img05.jpg GRAPHIC 11809
7 GRAPHIC tv522762_img06.jpg GRAPHIC 144010
8 GRAPHIC tv522762_img07.jpg GRAPHIC 169978
9 GRAPHIC tv522762_img08.jpg GRAPHIC 254615
10 GRAPHIC tv522762_img09.jpg GRAPHIC 329951
11 GRAPHIC tv522762_img10.jpg GRAPHIC 133253
12 GRAPHIC tv522762_img11.jpg GRAPHIC 429076
13 GRAPHIC tv522762_img12.jpg GRAPHIC 279043
  Complete submission text file 0001144204-19-029506.txt   3857306
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-37977 | Film No.: 19874216
SIC: 2834 Pharmaceutical Preparations